The analysis of the import of Blood, Antisera, Vaccines, Toxins, and Cultures to Indonesia shows significant fluctuations over the past decade. In 2023, the import value stood at 337.13 million US Dollars. From 2022 to 2023, there is a positive year-on-year variation of 4.47%, despite a slight dip of 0.21% from 2021 to 2022. The compound annual growth rate (CAGR) over the last five years is 3.87%. Future projections suggest a steady growth with expected values reaching 405.65 million US Dollars by 2028, yielding a forecasted 5-year CAGR of 2.85%.

Future trends to watch for include:

Increased demand for vaccines and medical cultures due to ongoing public health initiatives.
Potential market fluctuations influenced by global supply chain dynamics.
Technological advancements or regulatory changes impacting imports.